Evidence map›Paper›PMID 37744374›Full record

ArticleFrontiers in immunology2023

CD4

Salik Nazki, Vishwanatha R A P Reddy, Nitin Kamble, Jean-Remy Sadeyen, Munir Iqbal, Shahriar Behboudi, Holly Shelton, Andrew J Broadbent

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Flavonoids ofVeterinary sciences · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Salik NazkiThe Pirbright Institute, Woking, United Kingdom.
Vishwanatha R A P ReddyThe Pirbright Institute, Woking, United Kingdom.
Nitin KambleThe Pirbright Institute, Woking, United Kingdom.
Jean-Remy SadeyenThe Pirbright Institute, Woking, United Kingdom.
Munir IqbalThe Pirbright Institute, Woking, United Kingdom.
Shahriar BehboudiThe Pirbright Institute, Woking, United Kingdom.
Holly SheltonThe Pirbright Institute, Woking, United Kingdom.
Andrew J BroadbentThe Pirbright Institute, Woking, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007030Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007032Biotechnology and Biological Sciences Research Council BBS/E/I/00007035Biotechnology and Biological Sciences Research Council BBS/E/I/00007036Biotechnology and Biological Sciences Research Council BB/T008806/1
6 · The paper itself

Abstract

Introduction: Infectious Bursal Disease Virus (IBDV) causes immunosuppression in chickens. While B-cell destruction is the main cause of humoral immunosuppression, bursal T cells from IBDV-infected birds have been reported to inhibit the mitogenic response of splenocytes, indicating that some T cell subsets in the infected bursa have immunomodulatory activities. CD4 Methods: To evaluate if CD4 Results: Both 228E and F52/70 led to atrophy of the BF, a significant reduction of Bu1 Discussion: Our data suggest that an earlier infiltration of CD4

Indexed as

Infectious bursal disease virusAnimalsBursa of FabriciusChickensImmunosuppression TherapyTransforming Growth Factor betaTransforming Growth Factor betabursa of FabriciusCD4+CD25+ T cellsIBDVimmunosuppressionInfectious bursal disease virusregulatory T cellsTGFβ

Identifiers

PMID37744374
PMCPMC10515216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.